Skip to main content
Clinical Trials/NCT07324226
NCT07324226
Recruiting
Not Applicable

Effects of Combined Heat Application and Acupressure to the Carotid Artery Region on Cerebral Blood Flow in Healthy Adults: An Investigator-Initiated, Single-Group, Single-Center, Prospective Case Study

Pusan National University Yangsan Hospital1 site in 1 country9 target enrollmentStarted: February 1, 2026Last updated:

Overview

Phase
Not Applicable
Status
Recruiting
Enrollment
9
Locations
1
Primary Endpoint
A SPECT CT brain scan

Overview

Brief Summary

The aim of this study is to investigate the effects of combined heat application and acupressure to the carotid artery region on cerebral blood flow in healthy adults

Study Design

Study Type
Interventional
Allocation
Na
Intervention Model
Single Group
Primary Purpose
Basic Science
Masking
None

Eligibility Criteria

Ages
40 Years to 65 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • Adults aged 40 to 65 years.
  • Individuals with no history of cerebrovascular, cardiovascular, or neurological diseases.
  • Individuals who have signed the informed consent form and voluntarily agreed to participate in the study

Exclusion Criteria

  • Individuals with a history of cerebrovascular, cardiovascular, or neurological diseases (e.g., stroke, angina, epilepsy).
  • Individuals currently taking medications that may affect cerebral blood flow (such as antihypertensive agents or antidepressants).
  • Individuals with skin diseases or lesions that make it difficult to apply heat or acupressure devices to the carotid artery region, and individuals who are pregnant or breastfeeding.
  • Individuals with a history of seizures.
  • Individuals who have participated in clinical studies two or more times in the same year, or who have participated in another clinical study within the past 6 months.
  • Individuals who, in the judgment of the principal investigator or sub-investigator, have clinically significant findings that make them unsuitable for participation in this study.

Outcomes

Primary Outcomes

A SPECT CT brain scan

Time Frame: In the post-SPECT protocol, the radiopharmaceutical will be administered at 5 minutes (n=3), 10 minutes (n=3), and 20 minutes (n=3) after the start of image acquisition.

Cerebral blood flow change rate analysis: For each participant, the percentage change in cerebral blood flow (CBF) observed on SPECT imaging compared with the baseline time point will be quantitatively analyzed at the following three time points. Radiopharmaceutical injection reference times: 5 minutes, 10 minutes, and 20 minutes after injection.

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Yong-il Shin

Professor

Pusan National University Yangsan Hospital

Study Sites (1)

Loading locations...

Similar Trials